Montgomery Community Media

Novavax confirmed high levels of vaccine efficacy against both original and variant COVID-19 strains in recent United Kingdom and South Africa trials. In a press release Thursday, the Gaithersburg-based drug company said its vaccine has shown to provide 100% protection against severe disease, including hospitalizations and deaths. In a Phase 3 trial, Novavax reported a […]

Altimmune, Inc. announced Wednesday that it was approved by the FDA to begin Phase 1 clinical trials for AdCOVID, its single-dose nasal spray COVID-19 vaccine candidate. The clinical stage biopharmaceutical company, headquartered in Gaithersburg, expects to begin volunteer enrollment in the trials in the coming week, according to a statement from the company. “We believe […]

Novavax, a vaccine development company headquartered in Gaithersburg, announced Thursday that it entered into a Memorandum of Understanding (MOU) with an international vaccine organization to provide more than 1 billion total doses of Novavax’s COVID-19 vaccine candidate, according to a statement from the company. Novavax will work with Gavi, the Vaccine Alliance to provide 1.1 […]

Novavax, a vaccine development company headquartered in Gaithersburg, says its COVID-19 vaccine candidate showed 89.3% efficacy in UK clinical trials. The UK study enrolled more than 15,000 volunteers, according to a statement from Novavax on Thursday. More details will be released as data comes in, the company said. Phase 2b results in South Africa showed […]

Novavax, una empresa de desarrollo de vacunas con sede en Gaithersburg, ha iniciado la Fase 3 para su candidata a vacuna COVID-19. Es el quinto candidato en alcanzar la Fase 3 en EE. UU., después de Pfizer, Moderna, AstraZeneca y Janssen. Novavax está buscando voluntarios para participar en ensayos de vacunas, particularmente aquellos que son […]

Novavax, a vaccine development company headquartered in Gaithersburg, has initiated Phase 3 for its COVID-19 vaccine candidate.  It is the fifth candidate to reach Phase 3 in the U.S., after Pfizer, Moderna, AstraZeneca and Janssen. Novavax is looking for volunteers to participate in vaccine trials, particularly those who are part of at-risk populations like Hispanics, […]

Novavax, que tiene su sede en Gaithersburg e instalaciones en Rockville, anunció que ha pasado a la Fase 3 de su ensayo de eficacia para su vacuna COVID-19. Prevent-19 está diseñado para determinar la eficacia, seguridad e inmunogenicidad de su vacuna. Se espera inscribir hasta 30.000 voluntarios en todo Estados Unidos y México, de los […]

Novavax, which is headquartered in Gaithersburg and has facilities in Rockville, announced it has moved into Phase 3 of its efficacy trial for its COVID-19 vaccine. Prevent-19 is designed to determine the efficacy, safety and immunogenicity of its vaccine. It expects to enroll up to 30,000 volunteers throughout the United States and Mexico, of which […]

The COVID-19 pandemic has not hurt all industries. In Montgomery County, the life sciences sector, in particular, is expanding. “The pandemic has clearly taken a huge toll on not just our economy, locally, but also as you know, nationally as well. However we still continue to see pockets of growth, especially in the life sciences,” […]

Novavax, a vaccine development company in Gaithersburg, Md., released details for a $1.6 billion government contract for a COVID-19 vaccine on Nov. 11, according to NPR. The contract is part of the Trump Administration’s “Operation Warp Speed,” a program to make a vaccine available to the public in record time. Over the past several months, […]